Atlas Trials

Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis

Clinical trial NCT00436995 · COMPLETED

Trial details

NCT number
NCT00436995
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2006-04-01
Primary completion
2007-01-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.